课题基金 / 基金详情

The Safer Prescription of Opioids Tool USA Market feasibility study

The Safer Prescription of Opioids Tool USA Market feasibility study
更安全的阿片类药物处方工具美国市场可行性研究
批准号:
10018146
负责人:
金额:
$2.67万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SPOT - The Safer Prescription of Opioids Tool is a novel digital health platform, distributed as software as a service, which is proven to significantly improve the confidence of opioid prescribing and adherence to best practice guidelines. SPOT has been featured by the BBC and is one of SDI's top 12 Digital Health innovations to watch in 2020\. SPOT has been included in the Scottish Government's Coronavirus 19 palliative care response toolkit.Following a recent IUK project, SPOT has partnered with a UK and European-based professional publishing distributor, Class Professional Publishing. As of April 2021, SPOT is now available Europe-wide on their Salesforce platform, complemented with first-line sales and technical support.Building on specific contacts engendered over the last two years, our progress in the UK and European markets, and an increase in momentum for digital health from the COVID-19 pandemic, we seek to carry out a feasibility study with potential commercial partners in the USA who have already expressed interest in SPOT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金